Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine
NCT00655148
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
817
Enrollment
OTHER
Sponsor class
Conditions
Active Immunization
Interventions
BIOLOGICAL:
DTaP-IPV vero vaccine
BIOLOGICAL:
DTaP-IPV mkc vaccine
Sponsor
Statens Serum Institut